J&J misses sales mark in tough conditions

Chinese pharmacists works at Nep Star drug store in Shanghai, China on 13 July 2004

Company opts for buyback as dollar and competition crimp revenues

Merck names Stefan Oschmann as CEO

Leadership change comes as drugmaker looks to revitalise business

India chemists dispense nationwide strike

Up to 850,000 pharmacies to close doors over online drug sales

Eli Lilly Manufacturing handouts from website

Eli Lilly dives as it scraps heart drug

Trial into Evacetrapib abandoned due to ‘insufficient efficacy’

People walk by the JP Morgan & Chase Co. building in New York

Corporate diary

Net interest margins at JPMorgan to ‘bounce along the bottom’

File photo of nurse Pauline Cafferkey

Ebola nurse ‘serious’ as epidemic fades

Risks linger even as vaccines tested in Africa

Clinton, the TPP and the trust problem

The Democratic frontrunner’s about-turn does not do her credit

Big pharma thinks twice about price rises

Valeant and Allergan chiefs signal end to ‘buy and raise’ deals

Valeant’s business model faces scrutiny

US pharma group questioned about organic growth potential

Clinton opposes Obama Pacific trade deal

Move is blow to US president’s efforts to sell TPP to Congress

Express Scripts agrees heart drugs deal

Pharmacy group wins discount on medicine’s $14,000-a-year price

Axovant in late-stage Alzheimer’s trials

Group seeks go-ahead for first treatment for disease since 2003

Bristol-Myers settles China bribery claim

At least five western drugmakers have paid penalties over China corruption allegations since 2012

Smart pill bottle averts medical mishaps

Wharton MBA’s product reminds patients to take their medication

Cell Therapy eyes initial public offering

Cardiff-based company is developing regenerative medicines

Broccoli powers UK pharma group to float

Evgen Pharma joins procession of drug developers aiming to list

Week in Review, October 3

Shell’s broken Arctic dream; Valeant, digital ads and Liberty Global also in the news

Bayer cuts price range for Covestro IPO

Gross proceeds slashed from €2.5bn to €1.5bn after China worries

Healthcare junk bonds sting investors

Yields jump after drugs groups accused of price gouging

Cyborg brains are heading this way, soon

World must look beyond medical marvels of memory enhancement


Special report

insulin vials ©Jacob Ehrbahn Combating Diabetes

Special report

An elderly man uses a magnifier to see the descriptions on a pack of medicine at a pharmacy in Dandong, Liaoning province March 30, 2011 ©Jacky Chen/Reuter Health: Emerging Markets


More FT Twitter accounts